We are thrilled to announce that ExperTrials is the chosen CRO by Scynexis, Inc. for their phase II and by Vanda Pharmaceuticals, Inc. for a pivotal study (phase III).
We are thrilled to announce that ExperTrials is the chosen CRO by Scynexis, Inc. for their phase II and by Vanda Pharmaceuticals, Inc. for a pivotal study (phase III).